Titre : Rhodamine 123

Rhodamine 123 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Feeding and Eating Disorders
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Rhodamine 123 : Questions médicales les plus fréquentes", "headline": "Rhodamine 123 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Rhodamine 123 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-20", "dateModified": "2025-03-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Rhodamine 123" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Rhodamines", "url": "https://questionsmedicales.fr/mesh/D012235", "about": { "@type": "MedicalCondition", "name": "Rhodamines", "code": { "@type": "MedicalCode", "code": "D012235", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.600" } } }, "about": { "@type": "MedicalCondition", "name": "Rhodamine 123", "alternateName": "Rhodamine 123", "code": { "@type": "MedicalCode", "code": "D020112", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sreenivasulu Chintala", "url": "https://questionsmedicales.fr/author/Sreenivasulu%20Chintala", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA." } }, { "@type": "Person", "name": "Rachel A Katzenellenbogen", "url": "https://questionsmedicales.fr/author/Rachel%20A%20Katzenellenbogen", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA." } }, { "@type": "Person", "name": "Lu Wang", "url": "https://questionsmedicales.fr/author/Lu%20Wang", "affiliation": { "@type": "Organization", "name": "International Joint Research Center for Persistent Toxic Substances (IJRC-PTS), State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology, Harbin, 150090, China; International Joint Research Center for Arctic Environment and Ecosystem (IJRC-AEE), Polar Academy, Harbin Institute of Technology, Harbin, 150090, China." } }, { "@type": "Person", "name": "Fei Deng", "url": "https://questionsmedicales.fr/author/Fei%20Deng", "affiliation": { "@type": "Organization", "name": "School of Chemistry and Chemical Engineering, Jinggangshan University, Ji'an, Jiangxi 343009, China. Electronic address: dengfei@jgsu.edu.cn." } }, { "@type": "Person", "name": "Zhaochao Xu", "url": "https://questionsmedicales.fr/author/Zhaochao%20Xu", "affiliation": { "@type": "Organization", "name": "CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China. Electronic address: zcxu@dicp.ac.cn." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The Relationship Between Eating Disorders, Disordered Eating, and Injury in Athletes: A Critically Appraised Topic.", "datePublished": "2023-04-08", "url": "https://questionsmedicales.fr/article/37030667", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1123/jsr.2022-0370" } }, { "@type": "ScholarlyArticle", "name": "Changes in Eating Attitudes and Risk for Developing Disordered Eating Behaviors in College Students with Subthreshold Eating Disorders: A Cohort Study.", "datePublished": "2022-12-12", "url": "https://questionsmedicales.fr/article/36509080", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000527604" } }, { "@type": "ScholarlyArticle", "name": "HSE National Clinical Programme for Eating Disorders in Ireland: COVID-19 pandemic and eating disorder care in a new national eating disorder service.", "datePublished": "2023-04-25", "url": "https://questionsmedicales.fr/article/37097813", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/eat.23966" } }, { "@type": "ScholarlyArticle", "name": "Symptoms of Avoidant/Restrictive Food Intake Disorder among 2-10-Year-Old Children: The Significance of Maternal Feeding Style and Maternal Eating Disorders.", "datePublished": "2022-10-27", "url": "https://questionsmedicales.fr/article/36364790", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/nu14214527" } }, { "@type": "ScholarlyArticle", "name": "Eating Disorders and Metabolic Diseases.", "datePublished": "2023-01-30", "url": "https://questionsmedicales.fr/article/36767812", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20032446" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérocycliques 3 noyaux", "item": "https://questionsmedicales.fr/mesh/D006575" }, { "@type": "ListItem", "position": 5, "name": "Xanthènes", "item": "https://questionsmedicales.fr/mesh/D014966" }, { "@type": "ListItem", "position": 6, "name": "Rhodamines", "item": "https://questionsmedicales.fr/mesh/D012235" }, { "@type": "ListItem", "position": 7, "name": "Rhodamine 123", "item": "https://questionsmedicales.fr/mesh/D020112" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Rhodamine 123 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Rhodamine 123", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Rhodamine 123", "description": "Comment la Rhodamine 123 est-elle utilisée en diagnostic ?\nQuels tests utilisent la Rhodamine 123 ?\nLa Rhodamine 123 peut-elle indiquer des maladies ?\nQuel est le rôle de la Rhodamine 123 dans la recherche ?\nPeut-on mesurer la concentration de Rhodamine 123 ?", "url": "https://questionsmedicales.fr/mesh/D020112?mesh_terms=Feeding+and+Eating+Disorders&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Rhodamine 123", "description": "Quels symptômes sont associés à l'utilisation de Rhodamine 123 ?\nLa Rhodamine 123 provoque-t-elle des effets secondaires ?\nQuels signes indiquent une toxicité de la Rhodamine 123 ?\nLa Rhodamine 123 affecte-t-elle le système immunitaire ?\nY a-t-il des symptômes d'intoxication à la Rhodamine 123 ?", "url": "https://questionsmedicales.fr/mesh/D020112?mesh_terms=Feeding+and+Eating+Disorders&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Rhodamine 123", "description": "Comment prévenir les effets indésirables de la Rhodamine 123 ?\nY a-t-il des précautions à prendre avec la Rhodamine 123 ?\nLa formation est-elle nécessaire pour manipuler la Rhodamine 123 ?\nQuels sont les risques d'exposition à la Rhodamine 123 ?\nComment éliminer les déchets de Rhodamine 123 ?", "url": "https://questionsmedicales.fr/mesh/D020112?mesh_terms=Feeding+and+Eating+Disorders&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Rhodamine 123", "description": "Comment traiter une intoxication à la Rhodamine 123 ?\nLa Rhodamine 123 a-t-elle des applications thérapeutiques ?\nPeut-on utiliser la Rhodamine 123 en thérapie génique ?\nQuels médicaments interagissent avec la Rhodamine 123 ?\nLa Rhodamine 123 est-elle utilisée en oncologie ?", "url": "https://questionsmedicales.fr/mesh/D020112?mesh_terms=Feeding+and+Eating+Disorders&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Rhodamine 123", "description": "Quelles complications peuvent survenir avec la Rhodamine 123 ?\nLa Rhodamine 123 peut-elle causer des cancers ?\nQuels effets à long terme sont associés à la Rhodamine 123 ?\nY a-t-il des complications lors de l'utilisation en recherche ?\nComment minimiser les complications liées à la Rhodamine 123 ?", "url": "https://questionsmedicales.fr/mesh/D020112?mesh_terms=Feeding+and+Eating+Disorders&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Rhodamine 123", "description": "Quels sont les facteurs de risque liés à la Rhodamine 123 ?\nLes personnes sensibles doivent-elles éviter la Rhodamine 123 ?\nLes travailleurs en laboratoire sont-ils à risque ?\nY a-t-il des groupes vulnérables concernant la Rhodamine 123 ?\nComment évaluer le risque d'exposition à la Rhodamine 123 ?", "url": "https://questionsmedicales.fr/mesh/D020112?mesh_terms=Feeding+and+Eating+Disorders&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment la Rhodamine 123 est-elle utilisée en diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elle évalue la fonction mitochondriale dans les cellules par fluorescence." } }, { "@type": "Question", "name": "Quels tests utilisent la Rhodamine 123 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Elle est utilisée dans des tests de viabilité cellulaire et d'imagerie." } }, { "@type": "Question", "name": "La Rhodamine 123 peut-elle indiquer des maladies ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut signaler des dysfonctionnements mitochondriaux liés à diverses pathologies." } }, { "@type": "Question", "name": "Quel est le rôle de la Rhodamine 123 dans la recherche ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Elle aide à étudier les mécanismes de la toxicité cellulaire et des maladies." } }, { "@type": "Question", "name": "Peut-on mesurer la concentration de Rhodamine 123 ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, par des méthodes de spectroscopie et de cytométrie en flux." } }, { "@type": "Question", "name": "Quels symptômes sont associés à l'utilisation de Rhodamine 123 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation inappropriée peut entraîner des effets cytotoxiques, comme la mort cellulaire." } }, { "@type": "Question", "name": "La Rhodamine 123 provoque-t-elle des effets secondaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des effets secondaires peuvent survenir, notamment des réactions allergiques." } }, { "@type": "Question", "name": "Quels signes indiquent une toxicité de la Rhodamine 123 ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes de toxicité incluent des anomalies dans la respiration cellulaire." } }, { "@type": "Question", "name": "La Rhodamine 123 affecte-t-elle le système immunitaire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des études montrent qu'elle peut influencer la réponse immunitaire dans certains contextes." } }, { "@type": "Question", "name": "Y a-t-il des symptômes d'intoxication à la Rhodamine 123 ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "L'intoxication peut provoquer des symptômes comme des nausées ou des vertiges." } }, { "@type": "Question", "name": "Comment prévenir les effets indésirables de la Rhodamine 123 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des protocoles de sécurité appropriés lors de la manipulation en laboratoire." } }, { "@type": "Question", "name": "Y a-t-il des précautions à prendre avec la Rhodamine 123 ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, porter des équipements de protection individuelle pour éviter l'exposition." } }, { "@type": "Question", "name": "La formation est-elle nécessaire pour manipuler la Rhodamine 123 ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation adéquate est essentielle pour éviter les accidents." } }, { "@type": "Question", "name": "Quels sont les risques d'exposition à la Rhodamine 123 ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'exposition peut entraîner des irritations cutanées et des problèmes respiratoires." } }, { "@type": "Question", "name": "Comment éliminer les déchets de Rhodamine 123 ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les déchets doivent être éliminés selon les réglementations en vigueur pour les produits chimiques." } }, { "@type": "Question", "name": "Comment traiter une intoxication à la Rhodamine 123 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste à retirer l'exposition et à gérer les symptômes cliniques." } }, { "@type": "Question", "name": "La Rhodamine 123 a-t-elle des applications thérapeutiques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elle est principalement utilisée pour la recherche, pas comme traitement direct." } }, { "@type": "Question", "name": "Peut-on utiliser la Rhodamine 123 en thérapie génique ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Elle est étudiée pour son potentiel dans la thérapie génique, mais pas encore validée." } }, { "@type": "Question", "name": "Quels médicaments interagissent avec la Rhodamine 123 ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments affectant la fonction mitochondriale peuvent interagir avec elle." } }, { "@type": "Question", "name": "La Rhodamine 123 est-elle utilisée en oncologie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Elle est utilisée pour étudier la viabilité des cellules tumorales en recherche." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la Rhodamine 123 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des dommages cellulaires et des effets sur la santé à long terme." } }, { "@type": "Question", "name": "La Rhodamine 123 peut-elle causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des études sont nécessaires pour évaluer son potentiel cancérigène, mais des risques existent." } }, { "@type": "Question", "name": "Quels effets à long terme sont associés à la Rhodamine 123 ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des effets à long terme peuvent inclure des dysfonctionnements mitochondriaux chroniques." } }, { "@type": "Question", "name": "Y a-t-il des complications lors de l'utilisation en recherche ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des résultats biaisés peuvent survenir si les conditions expérimentales ne sont pas contrôlées." } }, { "@type": "Question", "name": "Comment minimiser les complications liées à la Rhodamine 123 ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "En suivant des protocoles stricts et en effectuant des contrôles réguliers." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque liés à la Rhodamine 123 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'exposition prolongée et la manipulation sans protection." } }, { "@type": "Question", "name": "Les personnes sensibles doivent-elles éviter la Rhodamine 123 ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes avec des allergies ou des sensibilités doivent l'éviter." } }, { "@type": "Question", "name": "Les travailleurs en laboratoire sont-ils à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont exposés à des risques accrus s'ils ne suivent pas les protocoles de sécurité." } }, { "@type": "Question", "name": "Y a-t-il des groupes vulnérables concernant la Rhodamine 123 ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants et les femmes enceintes sont considérés comme des groupes vulnérables." } }, { "@type": "Question", "name": "Comment évaluer le risque d'exposition à la Rhodamine 123 ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Évaluer le risque nécessite une analyse des conditions de travail et des mesures de sécurité." } } ] } ] }

Sources (10000 au total)

The Relationship Between Eating Disorders, Disordered Eating, and Injury in Athletes: A Critically Appraised Topic.

Eating disorders (EDs) and disordered eating (DE) result in numerous physical and psychological complications for female and male athletes. Besides bone-related injury, little research exists investig... Are EDs and/or DE a risk factor for injury incidence in athletes?... We searched for prospective studies assessing EDs or DE as a risk factor for injury in female or male athletes high school age and older. Our search returned 5 studies. One study found Eds, or DE were... Large and important gaps in the literature exist investigating injuries related to EDs or DE outside of BSIs. There is low-moderate evidence that EDs and/or DE are either a sole, or contributing, risk... Grade B evidence exists to support the idea that EDs and/or DE are a risk factor for a specific type of injury (BSI) in female athletes only....

Changes in Eating Attitudes and Risk for Developing Disordered Eating Behaviors in College Students with Subthreshold Eating Disorders: A Cohort Study.

The number of young adults with eating disorders or subthreshold eating disorders has increased recently. Although disordered eating behaviors persist once they appear, there have been relatively few ... A total of 1,141 college students, 639 males and 502 females, participated. We investigated changes in eating attitudes (using EAT-26 and BITE), depressive symptoms (using BDI-II), and stress coping (... The students in the subthreshold group (both males and females) scored significantly higher on the BDI-II and emotion-oriented coping (CISS-E) than the students in the healthy group at college entranc... Our results show that depressive symptoms and nonadaptive stress coping are associated with an increased risk of disordered eating behaviors. This study suggests that early intervention may be necessa...

HSE National Clinical Programme for Eating Disorders in Ireland: COVID-19 pandemic and eating disorder care in a new national eating disorder service.

The COVID-19 pandemic experience was different in each country (e.g., prevalence, societal restrictions). There is limited data on eating disorder (ED) diagnosis and service activity trends within Ire... Monthly data (2019-2021) from three regional community ED services (two-child and one-adult) were collected. National psychiatric and medical hospitalization data were analyzed. A descriptive and tren... There was a trend of referrals to community ED services during the COVID-19 pandemic for children (p < .0001) and adults (p = .0019). Albeit the increase in child referrals was evident at an earlier p... This study adds to the growing literature on the association of the COVID-19 pandemic on ED trends and the need for future public health and service provision funding to be allocated for mental health... This study illustrates the referral and hospitalization trend in young persons and adults with an ED in Ireland during the COVID-19 pandemic. This study highlights that there was a trend of Anorexia N...

Symptoms of Avoidant/Restrictive Food Intake Disorder among 2-10-Year-Old Children: The Significance of Maternal Feeding Style and Maternal Eating Disorders.

The aim of the present study was to investigate whether the feeding style and core behavioral features of eating disorders of mothers are related to the symptoms of Avoidant/Restrictive Food Intake Di...

Eating disorders in young people.

Eating disorders (EDs) have their onset most frequently in adolescence and young adulthood. Treatment for EDs lack efficacy, and we have made little progress in improving outcomes for patients over th... More effective evidence-based treatments are sorely needed for EDs, particularly for early stages of the illness to minimise the potential harms of treatment and long-standing illness. Treatment servi...

Psychopharmacologic Management of Eating Disorders.

Identifying medications that may be used as therapeutic agents for eating disorders is a longstanding focus of research, with varying degrees of success. The present review consolidates the most recen... Recent research suggests that olanzapine demonstrates positive effects on weight gain among outpatients with AN. There are fewer recent advances in psychopharmacological treatment for BN and BED, like...